522
Views
32
CrossRef citations to date
0
Altmetric
Papers

Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population

, , , &
Pages 423-430 | Published online: 15 Feb 2011

References

  • Bassotti G, Bellini M, Pucciani F, Bocchini R, Bove A, Alduini P, Battaglia E, Bruzzi P, Italian Constipation Study Group. 2004. An extended assessment of bowel habits in a general population. World J Gastroenterol. 10:713–716.
  • Camilleri M, Kerstens R, Rykx A, Vandeplassche L. 2008. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 358:2344–2354.
  • Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, . 2004. PASSCLAIM—gut health and immunity. Eur J Nutr. 43 Suppl 2: II118–II173.
  • Degen LP, Phillips SF. 1996. How well does stool form reflect colonic transit?. Gut. 39:109–113.
  • De Paula JA, Carmuega E, Weill R. 2008. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam. 38:16–25.
  • Ferrazzi S, Thompson GW, Irvine EJ, Pare P, Rance L. 2002. Diagnosis of constipation in family practice. Can J Gastroenterol. 16:159–164.
  • Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. 2004. Prevalence of constipation: Agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol. 159:520–526.
  • Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH. 2007. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 26:475–486.
  • Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. 2009. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: A randomised, double-blind, parallel, controlled study. Br J Nutr. 22:1–9.
  • Heaton KW, Ghosh S, Braddon FEM. 1991. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut. 32:73–79.
  • Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, . 2005. Tegaserod for treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 100:362–372.
  • Kikuchi H, Tajima T. 1992. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 60:139–146.
  • Koch GG, Gansky SA. 1996. Statistical considerations for multiplicity in confirmatory protocols. Drug Inform J. 30:523–533.
  • Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. 2003. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in subjects with chronic constipation. Can J Gastroenterol. 17:655–659.
  • Lewis SJ, Heaton KW. 1997. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 32:920–924.
  • Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 2006. Functional bowel disorders. Gastroenterology. 130:1480–1491.
  • Matsumoto K, Takada T, Shimizu K, Kado Y, Kawakami K, Makino I, Yamaoka Y, Hirano K, Nishimura A, Kajimoto O, Nomoto K. 2006. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: A randomized placebo-controlled cross-over study. Bioscince Microflora. 25:39–48.
  • McCrea GL, Miaskowski C, Stotts NA, Macera L, Hart SA, Varma MG. 2008. Review article: Self-report measures to evaluate constipation. Aliment Pharmacol Ther. 27:638–648.
  • O'Donnell LJD, Virjee J, Heaton KW. 1990. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit time. Br Med J. 300:439–440.
  • Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. 2008. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 8:5.
  • Probert CJS, Emmett PM, Heaton KW. 1993. Intestinal transit time in the population calculated from self made observations of defecation. J Epidemiol Community Health. 47:331–333.
  • Probert CJS, Emmett PM, Heaton KW. 1995. Some determinants of whole-gut transit time: a population based study. Q J Med. 88:311–315.
  • Quigley EMM, Vandeplassche L, Kerstens R, Ausma J. 2009. Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—A 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 29:315–328.
  • Shioiri T, Yahagi K, Nakayama S, Asahara T, Yuki N, Kawakami K, Yamaoka Y, Sakai Y, Nomoto K, Totani M. 2006. The effects of a symbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: A randomized placebo-controlled cross-over study. Biosci Microflora. 25:137–146.
  • Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. 2009. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut. 58:357–365.
  • Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, Bourdu-Naturel S. 2008. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol. 14:6237–6243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.